Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (701-710 of 1,050) with videos related to

Pageof 105
Sort By:
Annals of the Rheumatic Diseases|August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosisMarlene Krämer, Clara Dees, Jingang Huang, et al.
Annals of the Rheumatic Diseases|October 23, 2024
Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosisAleix Rius Rigau, Minrui Liang, Veda Devakumar, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)Maxime Dougados, Karsten Kissel, Tom Sheeran, et al.
Annals of the Rheumatic Diseases|May 6, 2016
WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritisGiovanna Nalesso, Bethan Lynne Thomas, Joanna Claire Sherwood, et al.
Rheumatology (Oxford, England)|October 19, 2017
Remission in psoriatic arthritis-where are we now?Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
Clinical Rheumatology|August 6, 2018
Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN studyDésirée van der Heijde, Patrick Durez, Georg Schett, et al.
Scientific Reports|June 24, 2026
Impact of personalized coaching on the use of digital health interventions for movement therapy in rheumatology: a randomized controlled trialMagdalena Binder, Alp Temiz, Paloma Palm von Alten Blaskowitz, et al.
Arthritis and Rheumatism|February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosisClara Dees, Pawel Zerr, Michal Tomcik, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Blockade of TNF-α rapidly inhibits pain responses in the central nervous systemAndreas Hess, Roland Axmann, Juergen Rech, et al.
Annals of the Rheumatic Diseases|January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulatorsAlexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Pageof 105

Showing results (701-710 of 1,050) with videos related to

Sort By:
Pageof 105
Annals of the Rheumatic Diseases|August 24, 2012
Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosisMarlene Krämer, Clara Dees, Jingang Huang, et al.
Annals of the Rheumatic Diseases|October 23, 2024
Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosisAleix Rius Rigau, Minrui Liang, Veda Devakumar, et al.
Annals of the Rheumatic Diseases|May 8, 2012
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)Maxime Dougados, Karsten Kissel, Tom Sheeran, et al.
Annals of the Rheumatic Diseases|May 6, 2016
WNT16 antagonises excessive canonical WNT activation and protects cartilage in osteoarthritisGiovanna Nalesso, Bethan Lynne Thomas, Joanna Claire Sherwood, et al.
Rheumatology (Oxford, England)|October 19, 2017
Remission in psoriatic arthritis-where are we now?Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
Clinical Rheumatology|August 6, 2018
Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN studyDésirée van der Heijde, Patrick Durez, Georg Schett, et al.
Scientific Reports|June 24, 2026
Impact of personalized coaching on the use of digital health interventions for movement therapy in rheumatology: a randomized controlled trialMagdalena Binder, Alp Temiz, Paloma Palm von Alten Blaskowitz, et al.
Arthritis and Rheumatism|February 12, 2011
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosisClara Dees, Pawel Zerr, Michal Tomcik, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Blockade of TNF-α rapidly inhibits pain responses in the central nervous systemAndreas Hess, Roland Axmann, Juergen Rech, et al.
Annals of the Rheumatic Diseases|January 10, 2018
Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulatorsAlexandru-Emil Matei, Christian Beyer, Andrea-Hermina Györfi, et al.
Pageof 105